BONSPRI
OFATUMUMAB
Public price
11,33 MAD
Active substance
OFATUMUMAB
Laboratory
NOVARTIS PHARMA
What is this medicine?
BONSPRI contains OFATUMUMAB. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
OFATUMUMAB, SOLUTION INJECTABLE EN SERINGUE PRE-REMPLIE DE 0.4 ML, 20 MG, BOITE DE 1 SERINGUE PRE-REMPLIE DE 0.4 ML
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Laboratory
NOVARTIS PHARMA
Hospital price
11,11 MAD
Strength
20 MG
Form
SOLUTION INJECTABLE EN SERINGUE PRE-REMPLIE DE 0.4 ML
Presentation
BOITE DE 1 SERINGUE PRE-REMPLIE DE 0.4 ML
Commercial status
Commercialisé
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 11,33 MAD